Sheila Gujrathi - 23 Dec 2024 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Director
Signature
/s/ Austin Rutherford, as Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
23 Dec 2024
Net transactions value
+$300,573
Form type
4
Filing time
26 Dec 2024, 20:05:18 UTC
Previous filing
07 Nov 2024
Next filing
06 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Purchase $300,573 +130,000 $2.31 130,000 23 Dec 2024 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 130,000 shares purchased in the price range of $2.275 to $2.38. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 The shares are held by the Jordan Yechiel Cohen and Sheila Kumari Gujrathi AB Living Trust, for which the Reporting Person serves as a co-trustee.